Home A reactive monocyte subset characterized by low expression of CD91 is expanded during sterile and septic inflammation
Article
Licensed
Unlicensed Requires Authentication

A reactive monocyte subset characterized by low expression of CD91 is expanded during sterile and septic inflammation

  • Christian Gosset EMAIL logo , Jacques Foguenne , Mickaël Simul , Nathalie Layios , Paul B. Massion , Pierre Damas and André Gothot
Published/Copyright: January 25, 2024

Abstract

Objectives

This study was undertaken to assess CD91 expression on monocytes and changes in monocyte subset distribution during acute tissue damage and bloodstream infection (BSI).

Methods

We investigated blood specimens from healthy individuals, trauma and cardiac surgery patients as a model of tissue damage, and patients with BSI, by flow cytometry using a panel of antibodies comprising CD45, HLA-DR, CD14, CD16 and CD91 for the identification of monocyte subsets.

Results

While infrequent in healthy subjects, CD91low/neg monocyte levels were markedly high in BSI, trauma and after cardiac surgery. This monocyte subset expanded up to 15-fold in both patient cohorts, whereas CD14+CD16+ inflammatory monocytes were multiplied by a factor of 5 only. CD14+CD91low monocytes displayed a significantly lower density of HLA-DR and markedly reduced expression of CD300e, compared to the other subsets. They also expressed high levels of myeloperoxidase and showed robust phagocytic and oxidative burst activity.

Conclusions

Expansion of CD91low monocytes is a sensitive marker of acute inflammatory states of infectious and non-infectious etiology.


Corresponding author: Christian Gosset, Department of Hematobiology and Immuno-Hematology, Liège University Hospital, Liège, Belgium, E-mail:

Acknowledgments

We thank the technical staff of the cytometry platform at CHU Liège for their contribution in performing the daily setup of the instruments.

  1. Research ethics: The local Institutional Review Board deemed the study exempt from review.

  2. Informed consent: Not applicable.

  3. Author contributions: A.G. and C.G. designed the study; C.G. designed and performed experiments; C.G. analyzed and interpreted data; C.G., J.F. and M.S. supervised flow cytometer setup and operation; P.B.M., N.L. and P.D. were involved in patient recruitment in the intensive care unit of the CHU de Liège, Belgium; A.G., C.G. wrote the manuscript; A.G., C.G., J.F., M.S., P.B.M., N.L. and P.D. revised the manuscript. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Competing interests: Authors state no conflict of interest.

  5. Research funding: None declared.

  6. Data availability: The raw data can be obtained on request from the corresponding author.

References

1. Ziegler-Heitbrock, L, Ancuta, P, Crowe, S, Dalod, M, Grau, V, Hart, DN, et al.. Nomenclature of monocytes and dendritic cells in blood. Blood 2010;116:74–80. https://doi.org/10.1182/blood-2010-02-258558.Search in Google Scholar PubMed

2. Shantsila, E, Wrigley, B, Tapp, L, Apostolakis, S, Montoro-Garcia, S, Drayson, MT, et al.. Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology. J Thromb Haemostasis 2011;9:1056–66. https://doi.org/10.1111/j.1538-7836.2011.04244.x.Search in Google Scholar PubMed

3. Rogacev, KS, Zawada, AM, Emrich, I, Seiler, S, Böhm, M, Fliser, D, et al.. Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease. Arterioscler Thromb Vasc Biol 2014;34:2120–7. https://doi.org/10.1161/atvbaha.114.304172.Search in Google Scholar

4. Zawada, AM, Fell, LH, Untersteller, K, Seiler, S, Rogacev, KS, Fliser, D, et al.. Comparison of two different strategies for human monocyte subsets gating within the large-scale prospective CARE FOR HOMe Study. Cytometry 2015;87:750–8. https://doi.org/10.1002/cyto.a.22703.Search in Google Scholar PubMed

5. Zawada, AM, Rogacev, KS, Rotter, B, Winter, P, Marell, RR, Fliser, D, et al.. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 2011;118:50–61. https://doi.org/10.1182/blood-2011-01-326827.Search in Google Scholar PubMed

6. Cros, J, Cagnard, N, Woollard, K, Patey, N, Zhang, SY, Senechal, B, et al.. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010;33:375–86. https://doi.org/10.1016/j.immuni.2010.08.012.Search in Google Scholar PubMed PubMed Central

7. Herz, J, Strickland, DK. LRP. A multifunctional scavenger and signaling receptor. J Clin Invest 2001;108:779–84. https://doi.org/10.1172/jci200113992.Search in Google Scholar

8. Lillis, AP, Van Duyn, LB, Murphy-Ullrich, JE, Strickland, DK. LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol Rev 2008;88:887–918. https://doi.org/10.1152/physrev.00033.2007.Search in Google Scholar PubMed PubMed Central

9. Robert, J, Ramanayake, T, Maniero, GD, Morales, H, Chida, AS. Phylogenetic conservation of glycoprotein 96 ability to interact with CD91 and facilitate antigen cross-presentation. J Immunol 2008;180:3176–82. https://doi.org/10.4049/jimmunol.180.5.3176.Search in Google Scholar PubMed

10. Cappelletti, M, Presicce, P, Calcaterra, F, Mavilio, D, Della Bella, S. Bright expression of CD91 identifies highly activated human dendritic cells that can be expanded by defensins. Immunology 2015;144:661–7. https://doi.org/10.1111/imm.12418.Search in Google Scholar PubMed PubMed Central

11. Gonias, SL, Campana, WM. LDL receptor-related protein-1: a regulator of inflammation in atherosclerosis, cancer, and injury to the nervous system. Am J Pathol 2014;184:18–27. https://doi.org/10.1016/j.ajpath.2013.08.029.Search in Google Scholar PubMed PubMed Central

12. Strickland, DK, Ranganathan, S. Diverse role of LDL receptor-related protein in the clearance of proteases and in signaling. J Thromb Haemostasis 2003;1:1663–70. https://doi.org/10.1046/j.1538-7836.2003.00330.x.Search in Google Scholar PubMed

13. Basu, S, Binder, RJ, Ramalingam, T, Srivastava, PK. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 2001;14:303–13. https://doi.org/10.1016/s1074-7613(01)00111-x.Search in Google Scholar PubMed

14. Hudig, D, Hunter, KW, Diamond, WJ, Redelman, D. Properties of human blood monocytes. I. CD91 expression and log orthogonal light scatter provide a robust method to identify monocytes that is more accurate than CD14 expression. Cytometry B Clin Cytom 2014;86:111–20. https://doi.org/10.1002/cyto.b.21131.Search in Google Scholar PubMed PubMed Central

15. Ferrer, DG, Jaldin-Fincati, JR, Amigone, JL, Capra, RH, Collino, CJ, Albertini, RA, et al.. Standardized flow cytometry assay for identification of human monocytic heterogeneity and LRP1 expression in monocyte subpopulations: decreased expression of this receptor in nonclassical monocytes. Cytometry 2014;85:601–10. https://doi.org/10.1002/cyto.a.22455.Search in Google Scholar PubMed

16. Gosset, C, Foguenne, J, Simul, M, Tomsin, O, Ammar, H, Layios, N, et al.. Machine learning identification of specific changes in myeloid cell phenotype during bloodstream infections. Sci Rep 2021;11:20288. https://doi.org/10.1038/s41598-021-99628-8.Search in Google Scholar PubMed PubMed Central

17. Manzoli, TF, Troster, EJ, Ferranti, JF, Sales, MM. Prolonged suppression of monocytic human leukocyte antigen-DR expression correlates with mortality in pediatric septic patients in a pediatric tertiary Intensive Care Unit. J Crit Care 2016;33:84–9. https://doi.org/10.1016/j.jcrc.2016.01.027.Search in Google Scholar PubMed

18. Greathouse, KC, Hall, MW. Critical illness-induced immune suppression: current state of the science. Am J Crit Care 2016;25:85–92. https://doi.org/10.4037/ajcc2016432.Search in Google Scholar PubMed

19. Monneret, G, Lepape, A, Voirin, N, Bohe, J, Venet, F, Debard, AL, et al.. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 2006;32:1175–83. https://doi.org/10.1007/s00134-006-0204-8.Search in Google Scholar PubMed

20. Passlick, B, Flieger, D, Ziegler-Heitbrock, HW. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989;74:2527–34. https://doi.org/10.1182/blood.v74.7.2527.bloodjournal7472527.Search in Google Scholar

21. Grage-Griebenow, E, Zawatzky, R, Kahlert, H, Brade, L, Flad, H, Ernst, M. Identification of a novel dendritic cell-like subset of CD64(+)/CD16(+) blood monocytes. Eur J Immunol 2001;31:48–56. https://doi.org/10.1002/1521-4141(200101)31:1<48::aid-immu48>3.3.co;2-x.10.1002/1521-4141(200101)31:1<48::AID-IMMU48>3.3.CO;2-XSearch in Google Scholar

22. Ancuta, P, Rao, R, Moses, A, Mehle, A, Shaw, SK, Luscinskas, FW, et al.. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med 2003;197:1701–7. https://doi.org/10.1084/jem.20022156.Search in Google Scholar

23. Wong, KL, Tai, JJ-Y, Wong, W-C, Han, H, Sem, X, Yeap, W-H, et al.. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 2011;118:e16–31. https://doi.org/10.1182/blood-2010-12-326355.Search in Google Scholar

24. Villani, A-C, Satija, R, Reynolds, G, Sarkizova, S, Shekhar, K, Fletcher, J, et al.. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science 2017;356:eaah4573. https://doi.org/10.1126/science.aah4573.Search in Google Scholar

25. Heimbeck, I, Hofer, TP, Eder, C, Wright, AK, Frankenberger, M, Marei, A, et al.. Standardized single-platform assay for human monocyte subpopulations: lower CD14+CD16++ monocytes in females. Cytometry 2010;77:823–30. https://doi.org/10.1002/cyto.a.20942.Search in Google Scholar

26. Rogacev, KS, Seiler, S, Zawada, AM, Reichart, B, Herath, E, Roth, D, et al.. CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease. Eur Heart J 2011;32:84–92. https://doi.org/10.1093/eurheartj/ehq371.Search in Google Scholar

27. Sutherland, DR, Illingworth, A, Marinov, I, Ortiz, F, Andreasen, J, Payne, D, et al.. ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 2 – reagent selection and assay optimization for high-sensitivity testing. Cytometry B Clin Cytom 2018;94:23–48. https://doi.org/10.1002/cyto.b.21610.Search in Google Scholar

28. Gaultier, A, Arandjelovic, S, Niessen, S, Overton, CD, Linton, MF, Fazio, S, et al.. Regulation of tumor necrosis factor receptor-1 and the IKK-NF-kappaB pathway by LDL receptor-related protein explains the antiinflammatory activity of this receptor. Blood 2008;111:5316–25. https://doi.org/10.1182/blood-2007-12-127613.Search in Google Scholar

29. May, P, Bock, HH, Nofer, J-R. Low density receptor-related protein 1 (LRP1) promotes anti-inflammatory phenotype in murine macrophages. Cell Tissue Res 2013;354:887–9. https://doi.org/10.1007/s00441-013-1699-2.Search in Google Scholar

30. Gorovoy, M, Gaultier, A, Campana, WM, Firestein, GS, Gonias, SL. Inflammatory mediators promote production of shed LRP1/CD91, which regulates cell signaling and cytokine expression by macrophages. J Leukoc Biol 2010;88:769–78. https://doi.org/10.1189/jlb.0410220.Search in Google Scholar

31. Fingerle, G, Pforte, A, Passlick, B, Blumenstein, M, Strobel, M, Ziegler-Heitbrock, HW. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 1993;82:3170–6. https://doi.org/10.1182/blood.v82.10.3170.bloodjournal82103170.Search in Google Scholar

32. Ziegler-Heitbrock, L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007;81:584–92. https://doi.org/10.1189/jlb.0806510.Search in Google Scholar PubMed

33. Raggi, F, Blengio, F, Eva, A, Pende, D, Varesio, L, Bosco, MC. Identification of CD300a as a new hypoxia-inducible gene and a regulator of CCL20 and VEGF production by human monocytes and macrophages. Innate Immun 2013;20:721–34. https://doi.org/10.1177/1753425913507095.Search in Google Scholar PubMed

34. Bronte, V, Brandau, S, Chen, S-H, Colombo, MP, Frey, AB, Greten, TF, et al.. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun 2016;7:12150. https://doi.org/10.1038/ncomms12150.Search in Google Scholar PubMed PubMed Central

35. Hamers, AAJ, Dinh, HQ, Thomas, GD, Marcovecchio, P, Blatchley, A, Nakao, CS, et al.. Human monocyte heterogeneity as revealed by high-dimensional mass cytometry. Arterioscler Thromb Vasc Biol 2019;39:25–36. https://doi.org/10.1161/atvbaha.118.311022.Search in Google Scholar PubMed PubMed Central

36. Merah-Mourah, F, Cohen, SO, Charron, D, Mooney, N, Haziot, A. Identification of novel human monocyte subsets and evidence for phenotypic groups defined by interindividual variations of expression of adhesion molecules. Sci Rep 2020;10:4397. https://doi.org/10.1038/s41598-020-61022-1.Search in Google Scholar PubMed PubMed Central

37. Reyes, M, Filbin, MR, Bhattacharyya, RP, Billman, K, Eisenhaure, T, Hung, DT, et al.. An immune-cell signature of bacterial sepsis. Nat Med 2020;26:333–40. https://doi.org/10.1038/s41591-020-0752-4.Search in Google Scholar PubMed PubMed Central

38. Vogel, C, Marcotte, EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 2012;13:227–32. https://doi.org/10.1038/nrg3185.Search in Google Scholar PubMed PubMed Central

39. Tauber, SC, Nau, R. Immunomodulatory properties of antibiotics. Curr Mol Pharmacol 2008;1:68–79. https://doi.org/10.2174/1874467210801010068.Search in Google Scholar

40. Markanday, A. Acute phase reactants in infections: evidence-based review and a guide for clinicians. Open Forum Infect Dis 2015;2:ofv098. https://doi.org/10.1093/ofid/ofv098.Search in Google Scholar PubMed PubMed Central


Supplementary Material

This article contains supplementary material (https://doi.org/10.1515/cclm-2023-0992).


Received: 2022-11-22
Accepted: 2023-12-26
Published Online: 2024-01-25
Published in Print: 2024-06-25

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. LC-MS/MS random access automation – a game changer for the 24/7 clinical laboratory
  4. Reviews
  5. Neurofilament light protein as a biomarker for spinal muscular atrophy: a review and reference ranges
  6. Differential diagnosis of ascites: etiologies, ascitic fluid analysis, diagnostic algorithm
  7. Opinion Papers
  8. Clinical Decision Support System in laboratory medicine
  9. Blood over-testing: impact, ethical issues and mitigating actions
  10. General Clinical Chemistry and Laboratory Medicine
  11. An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure for the quantification of zonisamide in human serum and plasma
  12. An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure for the quantification of carbamazepine in human serum and plasma
  13. An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure (RMP) for the quantification of phenobarbital in human serum and plasma
  14. An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure (RMP) for the quantification of primidone in human serum and plasma
  15. An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure for the quantification of carbamazepine-10,11-epoxide in human serum and plasma
  16. Should we depend on reference intervals from manufacturer package inserts? Comparing TSH and FT4 reference intervals from four manufacturers with results from modern indirect methods and the direct method
  17. Comparison of three chatbots as an assistant for problem-solving in clinical laboratory
  18. Evidence-based cutoffs for total and adjusted calcium: a major factor in detecting severe hypo- and hypercalcemia
  19. Minor head injury in anticoagulated patients: performance of biomarkers S100B, NSE, GFAP, UCH-L1 and Alinity TBI in the detection of intracranial injury. A prospective observational study
  20. A comparative evaluation of the analytical performances of premier resolution-high-performance liquid chromatography (PR-HPLC) with capillary zone electrophoresis (CZE) assays for the detection of hemoglobin variants and the quantitation of HbA0, A2, E, and F
  21. Get reliable laboratory findings – how to recognize the deceptive effects of angiotensin-converting enzyme inhibitor therapy in the laboratory diagnostics of sarcoidosis?
  22. Reference Values and Biological Variations
  23. Vitamin D and vitamin K status in postmenopausal women with normal and low bone mineral density
  24. Hematology and Coagulation
  25. An automatic analysis and quality assurance method for lymphocyte subset identification
  26. Cancer Diagnostics
  27. Machine learning-based delta check method for detecting misidentification errors in tumor marker tests
  28. Cardiovascular Diseases
  29. Analytical evaluation of the novel Mindray high sensitivity cardiac troponin I immunoassay on CL-1200i
  30. Infectious Diseases
  31. A reactive monocyte subset characterized by low expression of CD91 is expanded during sterile and septic inflammation
  32. Letters to the Editor
  33. Inadvertent omission of a specimen integrity comment – an overlooked post-analytical error
  34. Falsely elevated T3 due to interference of anti-T3 autoantibodies: a case report
  35. Validation of the Siemens Atellica cortisol immunoassay compared to liquid chromatography mass spectrometry in adrenal venous sampling for primary hyperaldosteronism
  36. Lessons learned from site-specific sampling and biological half-life of IGFII and IIE(68-88) peptide: a case study
  37. The added value of automated HPC count: detecting clinically important interferences on the flow cytometric CD34+ cell count
  38. Clinical pilot study on microfluidic automation of IGH-VJ library preparation for next generation sequencing
  39. Long-term effects of interventions applied to optimize the use of 25-OH vitamin D tests in primary health care
Downloaded on 8.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2023-0992/html
Scroll to top button